NCT04907877View on ClinicalTrials.gov

Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

March 1, 2023

Conditions
COVID-19 Respiratory Infection
Interventions
DIETARY_SUPPLEMENT

Probiotic

Probiotic will be taken 1 time a day before breakfast for 28 days.

DIETARY_SUPPLEMENT

Placebo

Placebo will be taken 1 time a day before breakfast for 28 days.

Trial Locations (3)

79014

Lviv State Center for Disease Control and Prevention, Lviv

79016

3rd City Clinical Hospital of Lviv, Lviv

88000

Hemo Medica Ukraine Ltd, Uzhhorod

All Listed Sponsors
lead

Nordic Biotic Sp. z o.o.

INDUSTRY

NCT04907877 - Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients | Biotech Hunter | Biotech Hunter